Log In
BCIQ
Print this Print this
 

Dutogliptin (REC-01) (formerly PHX1149)

  Manage Alerts
Collapse Summary General Information
Company Recardio Inc.
DescriptionDipeptidyl peptidase-4 (DPP-4) inhibitor
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase (DPP) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat acute myocardial infarction (AMI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$163.0M

$28.0M

$135.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/07/2009

$163.0M

$28.0M

$135.0M

Get a free BioCentury trial today